Lasse Kjaer (Lasse Kjær)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Chronic Myeloid Leukemia

High Throughput

Top Venues

European journal of haematology

British journal of haematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology 112 (5) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology 112 (5) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidities. Blood advances 8 (3) (2024)
Christina Schjellerup Eickhardt-Dalbøge, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O' Brien Andersen, Berit Lilje, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Lars Rønn Olsen, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen, Hans Carl Carl Hasselbalch, Anna Cäcilia Ingham
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European journal of haematology (2024)
Hans Carl Carl Hasselbalch, Marie Hvelplund Kristiansen, Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Troels Wienecke
CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties. Blood advances 8 (3) (2024)
Lasse Kjaer, Vibe Skov, Morten Kranker Larsen, Marie Hvelplund Kristiansen, Troels Wienecke, Sabrina Cordua, Christina Ellervik, Stephen E Langabeer, Hans Carl Hasselbalch
Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP. Molecular diagnosis & therapy (2024)
Morten Orebo Holmström, Josephine Hallundbæk Ruders, Caroline Hasselbalch Riley, Morten Kranker Larsen, Jacob Handlos Grauslund, Lasse Kjaer, Vibe Skov, Christina Ellervik, Belinda B Guo, Matthew Linden, Hans Carl Carl Hasselbalch, Mads Hald Andersen
The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets. British journal of haematology (2024)
Hans Carl Carl Hasselbalch, Vibe Skov, Lasse Kjaer, Morten Kranker Larsen
Proof of concept of triple COMBI therapy to prohibit MPN progression to AML. British journal of haematology (2023)
Vibe Skov, Mads Thomassen, Lasse Kjaer, Morten Kranker Larsen, Trine A Knudsen, Christina Ellervik, Torben A Kruse, Hans Carl Carl Hasselbalch
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms. European journal of haematology (2023)
Camilla Nordheim Solli, Sandra Chamat-Hedemand, Hanne Elming, Anh Ngo, Lasse Kjaer, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Hans Carl Carl Hasselbalch, Niels Eske Bruun
High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms. European journal of haematology (2023)
Laura Massarenti, Trine Alma Knudsen, Christian Enevold, Vibe Skov, Lasse Kjaer, Morten K Larsen, Thomas S Larsen, Dennis L Hansen, Hans C Hasselbalch, Claus H Nielsen
Interferon alpha-2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms. British journal of haematology (2023)
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O'Brien Andersen, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Carl Hasselbalch, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen
Pronounced gut microbiota signatures in patients with JAK2V617F- positive essential thrombocythemia. Microbiology spectrum (2023)
Morten Kranker Larsen, Vibe Skov, Lasse Kjaer, Natascha A Møller-Palacino, Rasmus K Pedersen, Morten Andersen, Johnny T Ottesen, Sabrina Cordua, Henrik E Poulsen, Morten Dahl, Trine A Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Steffen Koschmieder, Kasper M Pedersen, Yunus Çolak, Stig Egil Bojesen, Børge G Nordestgaard, Thomas Stiehl, Hans Carl Carl Hasselbalch, Christina Ellervik
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up. European journal of haematology 109 (5) (2022)
Marc J B Dam, Rasmus Kristoffer Pedersen, Trine Alma Knudsen, Morten Andersen, Christina Ellervik, Morten Kranker Larsen, Lasse Kjaer, Vibe Skov, Hans Carl Carl Hasselbalch, Johnny T Ottesen
A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon-alpha2. Cancer medicine (2022)
Marc J B Dam, Rasmus K Pedersen, Trine A Knudsen, Morten Andersen, Vibe Skov, Lasse Kjaer, Hans Carl Carl Hasselbalch, Johnny T Ottesen
Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis. European journal of haematology 107 (6) (2021)
Trine Alma Knudsen, Vibe Skov, Kristen E Stevenson, Lillian Werner, William Duke, Charles Laurore, Christopher James Gibson, Anwesha Nag, Aaron R Thorner, Bruce Wollison, Dennis Lund Hansen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weis Bjerrum, Ulrik Overgaard, Mikael Frederiksen, Thomas Kristensen, Torben Kruse, Mads Thomassen, Torben Mourits-Andersen, Marianne Tang Severinsen, Jesper Stentoft, Jørn Starklint, Donna Neuberg, Lasse Kjaer, Thomas S Larsen, Hans Carl Carl Hasselbalch, R Coleman Lindsley, Ann Mullally
Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses. Blood advances (2021)
Anders Lindholm Sørensen, Trine A Knudsen, Vibe Skov, Lasse Kjaer, Nanna Holm, Christina Ellervik, Hans Carl Hasselbalch
Smoking impairs molecular response, and reduces overall survival in patients with chronic myeloproliferative neoplasms: A retrospective cohort study. British journal of haematology 193 (1) (2020)
Rasmus Kristoffer Pedersen, Morten Andersen, Trine Alma Knudsen, Zamra Sajid, Johanne Gudmand-Hoeyer, Marc J B Dam, Vibe Skov, Lasse Kjaer, Christina Ellervik, Thomas Stauffer Larsen, Dennis Lund Hansen, Niels Pallisgaard, Hans Carl Carl Hasselbalch, Johnny T Ottesen
Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms. Cancer medicine 9 (6) (2020)
Sabrina Cordua, Lasse Kjaer, Vibe Skov, Niels Pallisgaard, Hans Carl Carl Hasselbalch, Christina Ellervik
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population. Blood 134 (5) (2019)
Nimesh A Jayasuriya, Alisa Devedzic Kjaergaard, Kasper Mønsted Pedersen, Anders Lindholm Sørensen, Marie Bak, Morten K Larsen, Børge Grønne Nordestgaard, Stig Egil Bojesen, Yunus Çolak, Vibe Skov, Lasse Kjaer, Janne Schurmann Tolstrup, Hans Carl Carl Hasselbalch, Christina Ellervik
Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people. British journal of haematology 189 (2) (2019)
Anders Lindholm Sørensen, Mads Emil Bjørn, Caroline H Riley, Morten Holmstrøm, Mads Hald Andersen, Inge Marie Svane, Stine Ulrik Mikkelsen, Vibe Skov, Lasse Kjaer, Hans Carl Carl Hasselbalch, Claus H Nielsen
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment. European journal of haematology 103 (4) (2019)
Lasse Kjaer, Vibe Skov, Morten T Andersen, Anni Aggerholm, Philippe Clair, Michal Gniot, Karen Soeby, Lene Udby, Mikkel H Dorff, Hans Hasselbalch, Niels Pallisgaard
Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay. European journal of haematology 103 (1) (2019)
Vardan Nersesjan, Kristoffer A Zervides, Anders Lindholm Sørensen, Lasse Kjaer, Vibe Skov, Hans Carl Carl Hasselbalch
The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera. European journal of haematology 104 (1) (2019)